An announcement from ZyVersa Therapeutics (ZVSA) is now available.
ZyVersa Therapeutics, Inc. stockholders gathered for a pivotal Special Meeting, voting in favor of a significant Reverse Stock Split, authorizing the board to choose a ratio from 1-for-2 up to 1-for-50. The board has decided on a 1-for-10 ratio, with the split expected to take effect in late April 2024, ushering in a new trading phase for the company on The Nasdaq Capital Market. This move reflects the company’s strategic efforts to adjust its stock structure and market position.
Find detailed analytics on ZVSA stock on TipRanks’ Stock Analysis page.
